Edit Háfra

发表

Phenoconversion of CYP 2 C 9 in epilepsy limits the predictive value of 2 CYP 2 C 9 genotype in optimizing valproate therapy 3 4

K. Monostory, K. Tóth, Adam Kiss, 2015 .

Phenoconversion of CYP2C9 in epilepsy limits the predictive value of CYP2C9 genotype in optimizing valproate therapy.

K. Monostory, K. Tóth, Adam Kiss, 2015, Personalized medicine.

Isoform-Dependent Changes in Cytochrome P450-Mediated Drug Metabolism after Portal Vein Ligation in the Rat

K. Monostory, M. Déri, Dávid Sirok, 2018, European Surgical Research.

Clinical significance of CYP2C9‐status guided valproic acid therapy in children

M. Garami, K. Monostory, K. Tóth, 2015, Epilepsia.

In response: Commentary on clinical significance of CYP2C9‐status‐guided valproic acid therapy in children

M. Garami, K. Monostory, K. Tóth, 2016, Epilepsia.

Role of Aspergilli and Penicillia in mycotoxin contamination of maize in Hungary

B. Tóth, Á. Mesterházy, M. Varga, 2012 .

Potential Role of Patients’ CYP3A-Status in Clozapine Pharmacokinetics

I. Bitter, G. Csukly, K. Monostory, 2017, The international journal of neuropsychopharmacology.

Optimization of Clonazepam Therapy Adjusted to Patient’s CYP3A Status and NAT2 Genotype

Ales Belic, István Bitter, Gábor Csukly, 2016, The international journal of neuropsychopharmacology.

Role of Aspergillus species in mycotoxin contamination of agricultural products in central Europe.

S. Kocsubé, J. Varga, B. Tóth, 2012 .

Personalizing initial calcineurin inhibitor dosing by adjusting to donor CYP3A-status in liver transplant patients.

K. Monostory, L. Kóbori, Adam Kiss, 2015, British journal of clinical pharmacology.